Passage Bio (PASG) Insider Trading & Ownership $0.46 +0.05 (+13.46%) Closing price 07/3/2025 03:36 PM EasternExtended Trading$0.46 0.00 (-0.22%) As of 07/3/2025 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Passage Bio (NASDAQ:PASG) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.30%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$408.10KNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$762.29K Get PASG Insider Trade Alerts Want to know when executives and insiders are buying or selling Passage Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PASG Insider Buying and Selling by Quarter Passage Bio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/26/2025Orbimed Advisors LlcMajor ShareholderSell213,257$0.33$70,374.81 6/25/2025Orbimed Advisors LlcMajor ShareholderSell138,800$0.33$45,804.00 6/24/2025Orbimed Advisors LlcMajor ShareholderSell231,600$0.35$81,060.00 4/24/2025Orbimed Advisors LlcMajor ShareholderSell68,195$0.32$21,822.40 4/22/2025Orbimed Advisors LlcMajor ShareholderSell78,049$0.34$26,536.66 4/17/2025Orbimed Advisors LlcMajor ShareholderSell77,090$0.33$25,439.70 4/15/2025Orbimed Advisors LlcMajor ShareholderSell10,326$0.38$3,923.88 1/13/2025Orbimed Advisors LlcMajor ShareholderSell17,986$0.64$11,511.04 1/10/2025Orbimed Advisors LlcMajor ShareholderSell126,209$0.66$83,297.94 1/8/2025Orbimed Advisors LlcMajor ShareholderSell75,007$0.68$51,004.76 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/6/2025Orbimed Advisors LlcMajor ShareholderSell19,481$0.77$15,000.37 12/27/2024Lynx1 Capital Management LpMajor ShareholderBuy373,645$0.65$242,869.25 12/20/2024Orbimed Advisors LlcMajor ShareholderSell230,321$0.60$138,192.60 12/11/2024Orbimed Advisors LlcMajor ShareholderSell80$0.80$64.00 12/9/2024Orbimed Advisors LlcMajor ShareholderSell54,181$0.84$45,512.04 12/6/2024Orbimed Advisors LlcMajor ShareholderSell20,903$0.82$17,140.46 12/4/2024Orbimed Advisors LlcMajor ShareholderSell76,200$0.79$60,198.00 11/27/2024Lynx1 Capital Management LpMajor ShareholderBuy29,300$0.67$19,631.00 11/25/2024Lynx1 Capital Management LpMajor ShareholderBuy259,998$0.56$145,598.88 9/18/2024Orbimed Advisors LlcMajor ShareholderSell25,631$0.73$18,710.63 9/16/2024Orbimed Advisors LlcMajor ShareholderSell63,100$0.74$46,694.00 (Data available from 1/1/2013 forward) PASG Insider Trading Activity - Frequently Asked Questions Who is on Passage Bio's Insider Roster? The list of insiders at Passage Bio includes Alexandros Fotopoulos, Kathleen Borthwick, Lynx1 Capital Management Lp, Mark S Forman, Orbimed Advisors Llc, Sandip Kapadia, and Simona King. Learn more on insiders at PASG. What percentage of Passage Bio stock is owned by insiders? 4.30% of Passage Bio stock is owned by insiders. Learn more on PASG's insider holdings. Which Passage Bio insiders have been buying company stock? The following insider purchased PASG shares in the last 24 months: Lynx1 Capital Management Lp ($408,099.13). How much insider buying is happening at Passage Bio? Insiders have purchased a total of 662,943 PASG shares in the last 24 months for a total of $408,099.13 bought. Which Passage Bio insiders have been selling company stock? The following insiders have sold PASG shares in the last 24 months: Kathleen Borthwick ($1,425.90), Mark S Forman ($15,978.69), Orbimed Advisors Llc ($762,287.29), and Simona King ($10,078.64). How much insider selling is happening at Passage Bio? Insiders have sold a total of 1,556,790 Passage Bio shares in the last 24 months for a total of $789,770.52 sold. More Insider Trading Tools from MarketBeat Related Companies TScan Therapeutics Insider Transactions Climb Bio Insider Transactions Surrozen Insider Transactions Jasper Therapeutics Insider Transactions Pliant Therapeutics Insider Transactions Zura Bio Insider Transactions ESSA Pharma Insider Transactions Pyxis Oncology Insider Transactions Acumen Pharmaceuticals Insider Transactions OKYO Pharma Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors?Insiders Chase Income and Stability in American Tower—Here’s Why3 Tech Stocks With High and Rising Institutional Interest This page (NASDAQ:PASG) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredFINAL HOURS: $9 Income ETF Access VANISHES at MIDNIGHTTHIS IS IT. Your FINAL CHANCE. At midnight, our 82% OFF July 4th deal disappears FOREVER. The countdown ...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Passage Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Passage Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
